Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral developmentArticle Published on 2023-04-242023-06-10 Journal: The Journal of Biological Chemistry [Category] Fulltext, 원숭이두창, [키워드] Actin Adenovirus Antiviral COVID-19 EPAC ESI-09 HSV-1 measles mpox Rho GTPases SARS-CoV-2 vaccinia. VSV [DOI] 10.1016/j.jbc.2023.104749 PMC 바로가기
Updated information regarding acute severe hepatitis of unknown origin in children: Viewpoints of and insights from pediatriciansArticle Published on 2023-03-112023-07-10 Journal: Bioscience trends [Category] COVID19(2023년), [키워드] acute severe hepatitis of unknown origin in children Adenovirus COVID-19 immune reaction. SARS-CoV-2 [DOI] 10.5582/bst.2022.01438 PMC 바로가기
In Vitro Antiviral and Anti-Inflammatory Activities of N-Acetylglucosamine: Development of an Alternative and Safe Approach to Fight Viral Respiratory InfectionsArticle Published on 2023-03-072023-06-24 Journal: International Journal of Molecular Sciences [Category] 신종인플루엔자, [키워드] Adenovirus Inflammation influenza A virus N-acetylglucosamine Nanotechnology viral respiratory infections. [DOI] 10.3390/ijms24065129 PMC 바로가기
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & JohnsonSARS-CoV-2 백신에 대한 포괄적인 검토: Pfizer, Moderna & Johnson & JohnsonReview Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Adenovirus administration age approval clinical clinical trial clinical trials coronavirus coronavirus. COVID-19 COVID-19 vaccine COVID-19 vaccines effective Efficacy General population group Johnson Johnson & Johnson Johnson & large cohort mechanism moderate Moderna mRNA vaccines Novel coronavirus ongoing trial ongoing trials outbreak pandemic participant Pfizer Safety SARS-CoV-2 SARS-CoV-2 coronavirus SARS-COV-2 infection shown Side effects Spike protein symptomatic SARS-CoV-2 infection tested the SARS-CoV-2 the spike protein the United State Trial United States Vaccinations Vaccine vaccine administration variant [DOI] 10.1080/21645515.2021.2002083 PMC 바로가기 [Article Type] Review
Clinical Outcomes Associated with SARS-CoV-2 Co-Infection with Rhinovirus and Adenovirus in Adults-A Retrospective Matched Cohort StudyArticle Published on 2022-12-302023-07-11 Journal: International Journal of Environmental Research an [Category] COVID19(2023년), [키워드] Adenovirus Biomarker Co-infection coronavirus disease 19 Mortality readmission Rhinovirus. SARS-CoV-2 [DOI] 10.3390/ijerph20010646 PMC 바로가기
Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2Article Published on 2022-12-072023-07-10 Journal: Molecular therapy : the journal of the American So [Category] COVID19(2023년), [키워드] Adenovirus protein superglue SARS-CoV-2 vaccine vector vector engineering. [DOI] 10.1016/j.ymthe.2022.08.002 PMC 바로가기
Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice근육내 및 비강내 상동 프라임-부스트를 침팬지 아데노바이러스 기반 COVID-19 백신과 결합하면 마우스에서 강력한 체액성 및 세포성 면역 반응을 이끌어냅니다.Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 addition Adenovirus adenovirus-based Adenovirus-vectored vaccine Administered antibody titres approach BALB/c mice booster Cellular immune response ChAdTS-S coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19 vaccine COVID-19 vaccines cytokine decrease Efficacy elicit elicited evaluated followed by group highest homologous humoral IFN-γ IFN-γ ELISPOT IgA IgG immune immune responses immunogenicity intracellular cytokine staining intramuscular intramuscular vaccination intranasal intranasal. Meso Scale Discovery mice prime immunization priming protocol provide pseudovirus neutralizing antibody respiratory responsible SARS-CoV-2 serotype shown T-cell Response T-cell responses tested titre vaccination Vaccine variants vectored vaccine [DOI] 10.1080/22221751.2022.2097479 PMC 바로가기 [Article Type] Article
Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variantsArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] addition adenoviral vector Adenovirus adenovirus type 5 vector vaccine Anti-RBD IgG booster COVID-19 COVID-19 vaccine D614G demonstrated dose effective Efficacy IgA immunization Inactivated vaccine Inactivated Vaccines Inhaled lack mucosal Neutralization assay Neutralizing neutralizing antibody omicron Omicron variant BA.5 pandemic plasma Protective RBD SARS-CoV-2 SARS-CoV-2 pseudovirus SARS-CoV-2 vaccines SARS-CoV-2 variant subunit titre Vaccination strategies vaccination strategies. Vaccination strategy Vaccine variant virus widespread [DOI] 10.1080/22221751.2022.2132881 PMC 바로가기
Virus contamination and infectivity in beach environment: Focus on sand and stranded materialArticle Published on 2022-12-012023-07-10 Journal: Marine pollution bulletin [Category] COVID19(2023년), [키워드] Adenovirus Beach cast coronavirus enterovirus Sand Virus persistence. [DOI] 10.1016/j.marpolbul.2022.114342 PMC 바로가기
Analysis of SARS-CoV-2 variants B.1.617: host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivitySARS-CoV-2 변이체 B.1.617 분석: 숙주 친화성, 단백질 분해 활성화, 세포-세포 융합 및 중화 민감도Article Published on 2022-12-012022-09-11 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] activity Adenovirus adenovirus vaccine Amino acid B.1.617 caused cell-cell fusion cell–cell fusion cells Characteristics Convalescent patients COVID-19 pandemic D614G variant Delta escaped furin host tropism human cells immunized inactivated Inactivated vaccine India Infection Infectivity L452R mAbs Mutation mutations neutralization neutralization activities neutralization activity neutralization. pathogenicity proteolytic activation pseudotyped pseudotyped virus Receptor binding domain reduced SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants sensitivity sera T478K Transmissibility transmitted variant variants viruses volunteers [DOI] 10.1080/22221751.2022.2054369 PMC 바로가기 [Article Type] Article